OIU — Test, Epithelial Ovarian Tumor Associated Antigen (He4) Class II

FDA Device Classification

Classification Details

Product Code
OIU
Device Class
Class II
Regulation Number
866.6010
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

An enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer. It is not intended to estimate or assess the risk of disease outcomes of patients.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K151378fujirebio diagnosticsLumipulse G HE4 Immunoreaction Cartridges, Lumipulse G HE4 CalibratorsNovember 24, 2015
K112624roche diagnosticsELECSYS HE4, ELECSYS HE4 CALSET, ELECSYS PRECICONTROL HE4, ELECSYS HE4 CALCHECK September 10, 2012
K103676fujirebio diagnosticsFUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROLJuly 19, 2011
K093957fujirebio diagnosticsARCHITECT HE4, ARCHITECT HE4 CALIBRATORS AND ARCHITECT HE4 CONTROLS, MODELS 2, 2March 18, 2010
K072939fujirebio diagnosticsHE4 EIA, MODEL: 404-10 USJune 9, 2008